UCB SA (UCB.BR)

EUR 169.35

(-0.03%)

Operating Expenses Summary of UCB SA

  • UCB SA's latest annual operating expenses in 2023 was 2.94 Billion EUR , down -5.87% from previous year.
  • UCB SA's latest quarterly operating expenses in 2024 Q2 was 1.61 Billion EUR , down 0.0% from previous quarter.
  • UCB SA reported a annual operating expenses of 3.25 Billion EUR in annual operating expenses 2022, up 7.82% from previous year.
  • UCB SA reported a annual operating expenses of 3.01 Billion EUR in annual operating expenses 2021, up 6.57% from previous year.
  • UCB SA reported a quarterly operating expenses of 1.2 Billion EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly operating expenses of 3.06 Billion EUR for 2023 FY, down -5.87% from previous quarter.

Annual Operating Expenses Chart of UCB SA (2023 - 2002)

Historical Annual Operating Expenses of UCB SA (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 2.94 Billion EUR -5.87%
2022 3.25 Billion EUR 7.82%
2021 3.01 Billion EUR 6.57%
2020 2.83 Billion EUR 17.9%
2019 2.4 Billion EUR 1.22%
2018 2.37 Billion EUR 5.75%
2017 2.24 Billion EUR 5.5%
2016 2.12 Billion EUR -3.89%
2015 2.21 Billion EUR 6.14%
2014 2.08 Billion EUR 8.2%
2013 1.92 Billion EUR -0.26%
2012 1.93 Billion EUR 5.98%
2011 1.82 Billion EUR 7.36%
2010 1.69 Billion EUR 60.95%
2009 1.05 Billion EUR -44.76%
2008 1.91 Billion EUR -8.0%
2007 2.07 Billion EUR 49.89%
2006 1.38 Billion EUR 1.84%
2005 1.36 Billion EUR -35.92%
2004 2.12 Billion EUR 11.05%
2003 1.91 Billion EUR 721.76%
2002 -307.36 Million EUR 0.0%

Peer Operating Expenses Comparison of UCB SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -70309.402%
ABIVAX Société Anonyme 127.37 Million EUR -2208.912%
Adocia SA 15.62 Million EUR -18717.583%
Aelis Farma SA 18.81 Million EUR -15527.823%
Biophytis S.A. 14.33 Million EUR -20419.082%
Advicenne S.A. 8.21 Million EUR -35700.365%
genOway Société anonyme 16.73 Million EUR -17470.497%
IntegraGen SA 5.35 Million EUR -54846.184%
Medesis Pharma S.A. 1.56 Million EUR -187874.73%
Neovacs S.A. 10.34 Million EUR -28333.192%
NFL Biosciences SA 4.37 Million EUR -67132.8%
Plant Advanced Technologies SA 2.76 Million EUR -106271.051%
Quantum Genomics Société Anonyme 1.71 Million EUR -171090.915%
Sensorion SA 27.05 Million EUR -10770.975%
Theranexus Société Anonyme 3 Million EUR -97770.64%
TME Pharma N.V. 5.49 Million EUR -53401.91%
Valbiotis SA 9.86 Million EUR -29700.385%
TheraVet SA 1.64 Million EUR -178758.891%
Valerio Therapeutics Société anonyme 20.32 Million EUR -14373.425%
argenx SE 1.34 Billion EUR -119.044%
BioSenic S.A. 7.58 Million EUR -38684.122%
Celyad Oncology SA 8.49 Million EUR -34540.754%
DBV Technologies S.A. 89.4 Million EUR -3189.496%
Galapagos NV 327.98 Million EUR -796.682%
Genfit S.A. 54.8 Million EUR -5266.397%
GeNeuro SA 14.35 Million EUR -20384.353%
Hyloris Pharmaceuticals SA 17.98 Million EUR -16250.698%
Innate Pharma S.A. 64.57 Million EUR -4454.747%
Inventiva S.A. 120.18 Million EUR -2347.04%
MaaT Pharma SA 21.59 Million EUR -13517.002%
MedinCell S.A. 32.92 Million EUR -8833.236%
Nanobiotix S.A. 58.92 Million EUR -4890.921%
Onward Medical N.V. 20.64 Million EUR -14145.58%
Oryzon Genomics S.A. 18.49 Million EUR -15799.784%
OSE Immunotherapeutics SA 23.58 Million EUR -12367.676%
Oxurion NV 12.21 Million EUR -23978.926%
Pharming Group N.V. 204.24 Million EUR -1339.904%
Poxel S.A. 28.76 Million EUR -10124.231%
GenSight Biologics S.A. 32.66 Million EUR -8904.899%
Transgene SA 31.23 Million EUR -9316.925%
Financière de Tubize SA 114.38 Thousand EUR -2570951.412%
Valneva SE 134.92 Million EUR -2079.746%
Vivoryon Therapeutics N.V. 24.69 Million EUR -11810.74%